Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 9, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 12, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001628280-26-007420
Filed / recorded
Feb 12, 2026, 12:11 AM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
BAXTER INTERNATIONAL INC
Issuer CIK
10456
Ticker
BAX
Reporting person
Maria Cecilia Soriano
Relationship
Officer
Officer title
Group Pres., ITT & Pharma.
Security
Common Stock, $1 par value
Table
Non-derivative (Table I)
Transaction date
Feb 9, 2026
Transaction code
A
Shares / units
2,273
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
56,924
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended.
